Eurofins Scientific (ERF) | Stock Overview & Key Data
Eurofins Scientific Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €620.20 on May 25, 2020
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.82B Large-cap | -2.31% | 6.92% | 3.43% | 8.79% | 2.23% | 6.23% | 4.20% | -30.63% | -80.05% | -29.49% | -29.49% | |
|
bioMérieux S.A
BIM
|
8.37B Large-cap | -6.77% | -5.86% | -28.78% | -37.02% | -38.40% | -43.82% | -26.63% | -26.39% | 78.29% | 224.16% | 224.16% |
|
Lumibird S.A
LBIRD
|
540.61M Mid-cap | -3.69% | 0.00% | 15.76% | 15.76% | 15.76% | 19.40% | 19.40% | 19.40% | 19.40% | 19.40% | 19.40% |
|
Eurofins Cerep SAS
ALECR
|
79.70M Small-cap | -11.56% | -3.77% | -15.00% | -8.93% | -14.04% | -25.73% | -47.24% | 13.33% | 205.88% | 512.00% | 512.00% |
|
Klea Holding
ALKLH
|
53.98M Small-cap | 5.56% | -5.00% | 5.56% | -17.39% | -13.64% | -5.26% | -5.26% | -5.26% | -5.26% | -5.26% | -5.26% |
|
Predilife S.A
ALPRE
|
12.22M Small-cap | 6.56% | -9.72% | -18.75% | -17.20% | -17.98% | -29.54% | -55.17% | -60.31% | -72.04% | -72.04% | -72.04% |
Ownership & Short Interest
Calculate Your Eurofins Scientific Investment Returns
Long-Term Investment Performance Analysis
Eurofins Scientific stock price in Jul 2016 was €341.70, A €1,000.00 lump sum investment in Eurofins Scientific made 9 years ago would be worth approximately €185.48 today, representing a negative return of -81.45%. This translates to an annualized return (CAGR) of -15.64%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ERF's 52-week high and low?
- In the last 52 weeks, Eurofins Scientific reached a high of €74.32 (on January 13, 2026) and a low of €54.86 (on November 21, 2025).
- What is the market cap and P/E ratio for ERF?
- Curious about Eurofins Scientific's size and valuation? Its market capitalization stands at 10.82B. When it comes to valuation, the P/E ratio (trailing twelve months) is 24.24, and the forward P/E (looking ahead) is 13.25.
- Does ERF pay dividends? If so, what's the yield?
- Yes, Eurofins Scientific is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.82%, and the company has paid an average of €1.03 per share annually over the past 3 years.
- Who are Eurofins Scientific's main competitors or similar companies to consider before investing?
When looking at Eurofins Scientific, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return bioMérieux S.A
BIM8.37B Healthcare Diagnostics & Research -43.82% -26.63% Lumibird S.A
LBIRD540.61M Healthcare Diagnostics & Research 19.40% 19.40% Eurofins Cerep SAS
ALECR79.70M Healthcare Diagnostics & Research -25.73% -47.24% Klea Holding
ALKLH53.98M Healthcare Diagnostics & Research -5.26% -5.26% Predilife S.A
ALPRE12.22M Healthcare Diagnostics & Research -29.54% -55.17% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Eurofins Scientific SE? (e.g., ROE, Debt/Equity)
- To get a sense of Eurofins Scientific's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 9.50%, the Debt to Equity ratio from the most recent quarter is 96.84, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ERF?
- Looking at Eurofins Scientific's growth, its revenue over the trailing twelve months (TTM) was €7B. Compared to the same quarter last year (YoY), quarterly revenue grew by 4.30%, and quarterly earnings saw a YoY growth of 22.90%.
- How much of ERF stock is held by insiders and institutions?
- Wondering who owns Eurofins Scientific stock? Company insiders (like executives and directors) hold about 36.50% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 34.99%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.